Heat Biologics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 10 of 10 Posts
E Market Briefing For Wednesday, September 9
Article By: Gene Inger Wednesday, September 9, 2020 3:58 AM EDT
S&P and big-cap-led Nasdaq continue cratering, not helped by the Apple hit, but particularly NDX, as the oft-warned about situation with Tesla unwinds.
In this article: AZN, GSK, JNJ, MRK, PFE, SNYNF, SRNE, NVAX, AAPL, SPY, MRNA, HTBX Also: QQQ, SPX, NYA, NDX
Read
E Market Briefing For Monday, Aug. 31
Article By: Gene Inger Sunday, August 30, 2020 8:03 PM EDT
This continues our case for continued erratic behavior (rotating on news too); but not catastrophe, even if you get a shakeout of juggernauts along the way.
In this article: SPX, ABT, BMY, PFE, INO, SRNE, MRNA, HTBX, VXRT
Read
E Market Briefing For Monday, July 27
Article By: Gene Inger Monday, July 27, 2020 1:15 AM EDT
There's a chasm between 'reality' and even economic survival now in some areas as well as greater risk if we don't get miraculous solutions soon. But you can also have a 'relief' rebound, if Congress comes together.
In this article: PFE, SRNE, MRNA, HTBX
Read
E Market Briefing For Monday, July 20
Article By: Gene Inger Sunday, July 19, 2020 8:40 PM EDT
Global urgency rises amid biotech shuffle. Aside individual stock focuses, emphasizes that this virus is a formidable foe.
In this article: AZN, SRNE, MRNA, SPX, HTBX
Read
3 Micro Cap Stocks That Are Worth Looking Into
Article By: Modest Money Tuesday, October 17, 2017 2:30 PM EDT
The best way to invest in micro caps is through an ETF or mutual fund so that you can limit potential risk.
In this article: FLL, HTBX, GNUS
Read
Heat Biologics (HTBX) Surges 30% On Investor Optimism
Article By: AO Markets Tuesday, November 29, 2016 3:00 AM EDT
Heat Biologics surged as much as 30% on Friday on increased investor optimism for trial results set to come out within the next few weeks. Results from its bladder cancer study will be released on November 30.
In this article: HTBX
Read
Heat Biologics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Thursday, July 21, 2016 3:40 PM EDT
Heat Biologics, Inc. announced today that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by Heat.
In this article: HTBX
Read
OncoSec Medical And Heat Biologics Collaborate On Immunotherapy Platforms
Article By: Terry Chrisomalis Wednesday, February 18, 2015 6:58 PM EDT
Oncosec and Heat Biologics form a collaboration deal to run pre-clinical trials in the coming months.
In this article: ONCS, HTBX, INO
Read
Depomed To Acquire U.S. Rights To NUCYNTA®, NUCYNTA® ER; Amgen Presents First-Line Use Of Vectibix®
Article By: BioMedReports Friday, January 16, 2015 3:44 AM EDT
Depomed Inc. announced it has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion.
In this article: DEPO, AMGN, DDD, ADXS, ALDX, AMBS, AMED, BSDM, BMRN, CBMG, DVCR, GALE, GB, HTBX, HEB, ISRG, OMED, PMCB, PRGB, RGDX, TGTX, WCUI
Read
Healthcare Review: FHCO, GOVX, HTBX, ARIA, INCY
Article By: BioMedReports Thursday, October 2, 2014 3:38 PM EDT
US stocks fluctuated amid an unexpected decline in jobless claims, while European equities plunged and the euro rose on concern additional stimulus will fail to boost inflation and revive the economy.
In this article: NVS, PFE, GOVX, ARIA, INCY, FHCO, HTBX
Read
1 to 10 of 10 Posts